| Literature DB >> 34552553 |
Huiping Wang1,2, Fen Wang1,3, Yushi Zhang4, Jin Wen4, Dexin Dong4, Xiaoyan Chang5, Hao Sun6, Xiaosen Ma1, Yunying Cui1, Shi Chen1, Lin Lu1, Weidong Ren2, Anli Tong1, Yuxiu Li1.
Abstract
Introduction: Previous studies on the surgical outcomes of aldosterone-producing adenoma (APA) patients were mainly based on the histopathological diagnosis of HE staining or adrenal venous sampling (AVS) instead of the functional pathology. The aim of the present study was to evaluate the surgical outcomes of APA patients based on the functional pathological diagnosis of APA according to HISTALDO (histopathology of primary aldosteronism) consensus.Entities:
Keywords: CYP11B2 (aldosterone synthase); aldosterone-producing adenoma (APA); computed tomography; hypokalemia; immunohistochemistry (IHC); surgical outcomes
Mesh:
Substances:
Year: 2021 PMID: 34552553 PMCID: PMC8451176 DOI: 10.3389/fendo.2021.663096
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1The procedure about preoperative diagnosis of APA, histopathology diagnosis and clinical outcomes. APA, aldosterone producing adenoma; APN, aldosterone-producing nodule; NFA, non-functional adenoma; APM, aldosterone-producing micronodule; MAPM, Multiple aldosterone-producing micronodules.
Clinical characteristics of patients with aldosterone-producing adenoma, aldosterone-producing nodule and non-functioning adenoma.
| Variable | APA (N = 123) | APN (N = 7) | NFA with APM or MAPM (N = 7) |
|---|---|---|---|
|
| 45 ± 10&& | 47 ± 7 | 57 ± 14 |
|
| 54/69 | 3/4 | 2/5 |
|
| 60 (24,120)*& | 12 (6,32)## | 126 (72,180) |
|
| 6 (3,24) | 6 (5,67) | 19 (1,36) |
|
| |||
|
| 182 ± 23 | 189 ± 27 | 179 ± 21 |
|
| 112 ± 13 | 108 ± 17 | 106 ± 10 |
|
| 2.5 ± 0.5 | 2.9 ± 0.3 | 2.8 ± 0.5 |
|
| 0.01 (0.01,0.03) | 0.01 (0.01,0.01) | 0.02 (0.01,0.02) |
|
| 20.3 ± 7.0& | 15.4 ± 3.6 | 14.4 ± 2.8 |
|
| 2.59 ± 0.69&& | 2.57 ± 0.71# | 3.51 ± 0.65 |
|
| 22% (27/122) | 0% (0/7) | 0% (0/7) |
|
| 10% (12/120) | 0% (0/7) | 29% (2/7) |
|
| 16% (20/122) | 29% (2/7) | 29% (2/7) |
|
| 34% (34/99) | 25% (1/4) | 33% (2/6) |
|
| 0% (0/123) | 0% (0/7) | 0% (0/7) |
|
| 17 (13,22)** | 8 (7,9)## | 23 (15,23) |
|
| 67/56& | 5/2 | 7/0 |
|
| 2.0 (-5.0,7.3) | 5.2 (-9.2,12.4) | 3.3 (-5.2,5.1) |
|
| |||
|
| 128 ± 12& | 130 ± 10 | 140 ± 29 |
|
| 84 ± 8 | 83 ± 6 | 86 ± 12 |
|
| 4.2 ± 0.4 | 4.1 ± 0.3 | 4.0 ± 0.1 |
|
| 54% (67/123) | 43% (3/7) | 43% (3/7) |
|
| 28% (34/123) | 57% (4/7) | 57% (4/7) |
|
| 0% (0/123) | 0% (0/7) | 0% (0/7) |
*P < 0.05 **P < 0.01 APA vs.APN; #P < 0.05 ##P < 0.01 APN vs. NFA; &P < 0.05 &&P < 0.01 APA vs. NFA.
APA, aldosterone-producing adenoma; APN, aldosterone-producing nodule; NFA, non-functioning adenoma; MAPM, multiple aldosterone-producing micronodule; APM, aldosterone-producing micronodule; PRA, plasma renin activity; PAC, plasma aldosterone concentration.
Comparison of clinical characteristics between 130 patients with classical histopathologic findings with complete and partial clinical success.
| Variable | Complete (N = 70) | Partial (N = 60) | P value |
|---|---|---|---|
|
| 44 ± 10 | 46 ± 10 | 0.195 |
|
| 26/44 | 31/29 | 0.096 |
|
| 48 (11,120) | 72 (39,120) | 0.005 |
|
| 6 (3,22) | 9 (4,24) | 0.153 |
|
| |||
|
| 174 ± 18 | 192 ± 26 | <0.001 |
|
| 107 ± 10 | 117 ± 15 | <0.001 |
|
| 2.5 ± 0.5 | 2.5 ± 0.5 | 0.915 |
|
| 0.01 (0.01,0.01) | 0.01 (0.01,0.06) | 0.446 |
|
| 19.7 ± 7.0 | 20.5 ± 6.9 | 0.535 |
|
| 2.62 ± 0.70 | 2.55 ± 0.68 | 0.600 |
|
| 24% (17/70) | 17% (10/59) | 0.330 |
|
| 4% (3/68) | 15% (9/59) | 0.103 |
|
| 13% (9/70) | 22% (13/59) | 0.214 |
|
| 32% (18/56) | 36% (17/47) | 0.887 |
|
| 0% (0/70) | 0% (0/60) | —— |
|
| 15.0 (12.3,20.0) | 16.5 (13.0,21.5) | 0.780 |
|
| 35/35 | 37/23 | 0.182 |
|
| 2.0 (-5.5,5.0) | 5.0 (-4.7,8.8) | 0.041 |
|
| |||
|
| 122 ± 9 | 136 ± 11 | <0.001 |
|
| 79 ± 5 | 89 ± 7 | <0.001 |
|
| 4.3 ± 0.4 | 4.2 ± 0.3 | 0.045 |
|
| 0% (0/70) | 63% (38/60) | <0.001 |
|
| 0% (0/70) | 0% (0/60) | —— |
Figure 2(A) Cure rate of hypertension in the group with hypertension during less than 5 years, more than 5 years and 10 years (68% vs. 45% vs 42%); (B) Cure rate of hypertension in the group with SBP<160 mmHg group, 160 mmHg≤SBP<180 mmHg group and SBP≥180 mmHg group (87% vs. 63% vs 44%); (C) Cure rate of hypertension in the group with DBP<100mmHg group, 100mmHg≤DBP < 120mmHg group and DBP≥120mmHg group(90% vs. 62% vs. 46%).
Estimates of parameters of logistic regression model for complete clinical success of patients with classical histopathologic findings.
| Variables | Coefficient | SE | Wald | P-value | OR (95% CI) |
|---|---|---|---|---|---|
|
| 1.137 | 0.435 | 6.828 | 0.009 | 3.118 (1.329 to 7.31) |
|
| 0.006 | 0.003 | 4.916 | 0.027 | 1.006 (1.001 to 1.01) |
|
| 0.042 | 0.011 | 14.714 | 0.000 | 1.043 (1.021 to 1.066) |
|
| -8.909 | 2.104 | 17.924 | 0.000 | 0.000 |
CI, confidence interval.
Figure 3ROC curve in patients by adding variables as gender,duration of hypertension and the highest SBP.